Meiji Yasuda Life Insurance CO Neurocrine Biosciences Inc Transaction History
Meiji Yasuda Life Insurance CO
- $4.99 Billion
- Q1 2025
A detailed history of Meiji Yasuda Life Insurance CO transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Meiji Yasuda Life Insurance CO holds 5,606 shares of NBIX stock, worth $718,577. This represents 0.01% of its overall portfolio holdings.
Number of Shares
5,606
Previous 5,800
3.34%
Holding current value
$718,577
Previous $791,000
21.62%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding NBIX
# of Institutions
649Shares Held
97.6MCall Options Held
749KPut Options Held
553K-
Black Rock Inc. New York, NY14.2MShares$1.82 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.94MShares$1.27 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.53MShares$709 Million0.37% of portfolio
-
State Street Corp Boston, MA4.86MShares$623 Million0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY2.67MShares$342 Million0.02% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $12.3B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...